EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Other financing activities (2011 - 2026)

EyePoint (EYPT) posted Other financing activities of $606000.0 for Q1 2026, up 72.65% sequentially from $351000.0 in Q4 2025, and up 170.54% YoY from $224000.0 in Q1 2025.

Analysis

EyePoint (EYPT) Other financing activities (2011 - 2026) Analysis & Trends

EyePoint has reported Other financing activities for 14 years, with the latest figure at $606000.0 in Q1 2026.

  • Quarterly Other financing activities rose 170.54% year-over-year to $606000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 55.45% YoY) and the FY2025 annual result came in at $1.5 million, down 73.39% from the prior year.
  • Other financing activities advanced to $606000.0 in Q1 2026 per EYPT's latest filing, from $351000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $4.6 million in Q1 2024 and troughed at -$354000.0 in Q4 2022.
  • A 5-year average of $662562.5 and a median of $262000.0 in 2024 frame the typical range for Other financing activities.
  • The sharpest annual moves came in 2022 and 2024: Other financing activities tumbled 497.75% in 2022, then jumped 12400.0% in 2024.
  • Over 5 years, Other financing activities stood at -$354000.0 in 2022, then jumped by 636.44% to $1.9 million in 2023, then slumped by 95.16% to $92000.0 in 2024, then soared by 281.52% to $351000.0 in 2025, then soared by 72.65% to $606000.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods registered $606000.0, $351000.0, and $623000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 597,000.00
Mar 31, 2026 606,000.00
Dec 31, 2025 351,000.00
Sep 30, 2025 623,000.00
Jun 30, 2025 273,000.00
Mar 31, 2025 224,000.00
Dec 31, 2024 92,000.00
Sep 30, 2024 251,000.00
Jun 30, 2024 625,000.00
Mar 31, 2024 4.56 Mn
Dec 31, 2023 1.90 Mn
Sep 30, 2023 803,000.00
Jun 30, 2023 5,000.00
Mar 31, 2023 248,000.00
Sep 30, 2022 154,000.00
Mar 31, 2022 241,000.00
Dec 31, 2021 89,000.00
Sep 30, 2021 101,000.00
Mar 31, 2021 183,000.00
Sep 30, 2020 107,000.00